Abstract
OBJECTIVES: The aim of the study was to ascertain whether rilmenidine, a second generation imidazoline-alpha-2-adrenoreceptor agonist, is able to increase analgesic effects of Ibuprofen in the writhing test in mice. Experimental studies combining these agents have not yet been published.
METHODS: An acetic acid (0.7%) solution was injected into the peritoneal cavity and the number of writhes was counted. The influence on locomotor performance was tested using the rotarod test.
RESULTS: Rilmenidine, Ibuprofen, and rilmenidine-ibuprofen fixed-ratio combinations produced dose-dependent antinociceptive effects. ED50 values were estimated for the individual drugs and an isobologram was constructed.
The derived theoretical additive ED50 value for the rilmenidine-ibuprofen combination was 34.00 +- 9.39 mg/kg. This value was significantly greater than the observed ED50 value which was 18.07 +- 5.41 mg/kg, indicating a synergistic interaction.
Rilmenidine did not impair motor coordination, as measured by the rotarod test, at antinociceptive and higher doses. CONCLUSIONS: The present results suggest that rilmenidine enhances the analgesic activity of Ibuprofen.
If rilmenidine produces antinociception in humans, then the synergistic antinociception of rilmenidine with ibuprofen could offer therapeutic advantage for clinical treatment of pain.